Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Itopride HCl versus placebo in functional dyspepsia
2004-000448-26Phase 3Completed
- Sponsor
- Axcan Pharma Inc.
- Start
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in functional dyspepsia (FD) comparing ITAX with Placebo (2 arms). Primary endpoints: Change in adapted Leeds Dyspepsia Questionnaire overall severity using upper abdominal pain and fullness items and Global Patient Assessment of Efficacy. Started Jun 2005; status: completed.
02
Drugs
itopride
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on 2004-000448-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000448-26.